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Synopsis
The reactivities of the aldol condensations of pyruvate with isomeric pyridinecarboxaldehydes and benzaldehyde
were examined in the presence of hexakis-, heptakis- and octakis-(2,3-di-O-methyl-6-amino-6-deoxy)-a-, (3-
and y cyclodextrins (a-, ~- and y-PACDs) in water at pH 4.5. It was found that (3-PACD was a more reactive
catalyst than other PACDs for the condensation of pyruvate with 3-pyridinecarboxaldehyde, and the imine
formation and the host-guest complexation in the ternary complex should be important to promote the
condensation reactions, because this condensation was completely inhibited by the presence of pyrene that was
included into the cavity of p-PACD.
KEYWORDS: Aldol condensation, Host-guest complex, Imine formation, Peraminated cyclodextrins, Pyruvate,
Pyridinecarboxaldehyde, Pyrene
Introduction
A large number of aldolases play important roles in the biosynthetic condensations of ketones with aldehydes.
For example, 2-keto-3-deoxy-6-phosphogluconic aldolase (Class I aldolase) catalyzes reversible condensation
of pyruvate with glyceraldehyde 3-phosphate, where the mechanistic studies suggested an imine formation
between a lysine £-amino group and aldehydes and an additional base function (probably another distinct lysine)
for cleavage and condensation should be presented in the active site. This enzyme also catalyzes the proton
exchange between solvent protons and methyl protons of pyruvate, and catalyze the decarboxylation of
oxalacetate. I,2
We previously reported that heptakis-(2,3-di-O-methyl-6-amino-6-deoxy)-~-cyclodextrins(~-PACD),
peraminated ~-CD on the 6 position, was a active catalyst for the decarboxylation of oxalacetate and for the
aldol condensation of pyruvate with pyridinecarboxaldehyde, as a model of lysine enzymes, via an inclusion
complex of the imine intermediate of J3-PACDIPA with pyridinecarboxaldehyde·3-5 We would like to report
here further results to delineate the scope of this catalytic system.
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Results and Discussion
Aldol condensations are catalyzed by bases, acids and amines in organi<; media. Hexakis-, heptakis- and octakis
(2,3-di-O-methyl-6-amino-6-deoxy)-a-, ~- and y-cyclodextrins (a-, ~- and y-PACDs) and 6-monoamino-6-
deoxy heptakis-(2,3-di-O-methyl)-f3-cyclodextrin (MA-I) as amino catalysts were synthesized from the
corresponding (2,3-di-O methyl)-cyclodextrins. These modified PACDs are unique molecules having 6-8
primary amino groups aligned in a parallel way around on a circumference of cylindrical molecules. From the
previous kinetic studies, ~-PACDwas an effective catalyst for the H-D exchange of methyl protons of pyruvate
(PA) in D20, compared with ethylenediamine (ED) or aminoacetonitrile.4
We examined the condensation of PA with benzaldehyde and isomeric pyridinecarboxaldehydes in the
presence and absence of the catalytic amount of ~-PACD at pH 4.5 and 50°C for 3 days. The product yields,
from the reaction mixture adding nicotinic acid as an internal standard, were determined by using HLPC; 4-
phenyl-2-keto-3,4-butenoic acid (32 %) and 4-(2-pyridyl)- (63 %), 4-(3-pyridyl)- (85 %), and 4-(4 pyridyl)-2-
keto-3,4-butenoic acid (87 %) from benzaldehyde and 2-,3-, and 4-pyridinecarboxaldehyde, respectively.4
Figure 1 presents the product yields for aldol condensation of PA and 3-pyridinecarboxaldehydee (3-PyCHO)
on ratios of 1/5, III and 5/1 in the presence of a catalytic amount (1/100 eq. mol) of ~-PACD. The yield was
almost 100 % after 1 day on lIS ratio of [PA]/[3-PyCHO] but the conversion increased slightly after 4 days on
1/1 ratio. However, the aldol condensation products could not be observed in the absence of ~-PACD.
Figure 2 shows the conversions vs reaction time for the aldol condensation of PA (0.1 M) with 3-PyCHO
(0.5 M) catalyzed by various amines (I mM).
The conversions were saturated for PACDs after 2 or 3 days in the catalytic order of ~- > y- ~ (l-PACD,
whereas ED and MA-l had low catalytic behaviors. From the CPK model study, the inclusion complex should
be suitable for ~-PACDwith 3-PyCHO, but (l-PACD has a small cavity and y-PACD was too large to include
3-PyCHO. The reaction of 3-PyCHO with acetone did not proceed in these conditions and monoamino-~-CD
(MA-1) had a low reactivity. Thus, the imine intermediate of PA with ~-PACDwhen formed appears to be
stabilized by an electrostatic interaction with the neighboring protonated amino groups in the first stage.
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Fig. 2 Conversion (%) vs. reaction time (days) for the
aldol condensation of PA with 3-PyCHO catalyzed
by various amines at pH 4.5, 50°C, [PA]=O.l M,
[3-PyCHO]=0.5 M, [amine]=l mM.
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Fig. 1 Conversion (%) vs. reaction time (days) for the aldol
condensation of PA with 3-PyCHO at pH 4.5, 50°C, (a)
[PA]=O.1 M, [3-PyCHO]=0.5 M, [P-PACD]=lmM;
(b) [PA]=[3-PyCHO]=0.1 M, [~-PACD]=lmM; (c)
[PA]=0.5 M, [3-PyCHO]=O.1 M, [~-PACD]= ImM; (d)
[PA]=O.1 M, [3-PyCHO]=O.5 M, [J3-PACD]=O.
100
~
c: 80
0
·Vi
'-Cl)
>
c:
0 60u
40
20
0
0
In the second stage, it is likely that the above enhancement of the catalytic activity for 3-PyCHO should be
due to its inclusion into the cavity of ~-PACD. To confirm this possibility, the competitive inclusion between
3-PyCHO and pyrene into the cavity of ~-PACDwas examined.
It is known that pyrene could be included as an inclusion complex into the P-CD cavity which has a suitable
size in 1: 1 ratio of ~-CD/pyrene6,and y-CD also includes pyrene in 2: I or 2:2 ratio of y-CD/pyrene.6b•7
103
4
20% EtOH
3
o
o 2
days
Fig. 3 Inhibition by pyrene and solvent effect of EtOH for the
aldol condensation of PA with 3-PyCHO at pH 4.5, 50°C,
[PAl=0.5 M, [3-PyCHOl=0.1 M, [ ~-PACD]=[pyrene]=lmM.
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Pyrene could not be soluble in this buffer
solution, thus we added ethanol (20 % v/v) into
this buffer, although the addition of ethanol gave
lower conversions for this reaction. As shown in
Fig. 3, in the absence of pyrene the conversion was
saturated at about 70 % after 1 day, but by the
presence of an equivalent amount of pyrene with
~-PACD the aldol condensation was completely
inhibited. From this and other observations, pyrene
should expel3-PyCHO from the cavity of ~-PACD
and inhibit the formation of the inclusion complex
of an imine inermediate with 3-PyCHO.
A bell-shaped curve of the aldol condensation
of ~-PACDwith 3-PyCHO having a maximum at
pH 4.5, the same as the kinetic studies of this
condensationS and the decarboxylation of
oxalacetate catalyzed by ~-PACD,3 suggests that
the rate determining step of this aldol condensation
catalyzed by ~-PACD should be in an imine
formation. The present amine catalysis proceeds
through the imine formation and the inclusion
complex of this intermediate with pyridinecarbox-
aldehyde as shown in Scheme 2.
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Schme 2 Fonnation of imine intermediate and
inclusion complexes
~-PACD and PA could form an imine intermediate with an ion-pairing between the adjacent ammonium and
carboxylate groups in Scheme 2 and 3-PyCHO should be included into the hydrophilic cavity of this imine
intermediate to facilitate the aldol condensation. Thus, neighboring animo groups and the cavity of ~-PACD
should be necessary for its activity.
Recently, we reported that 3-endo-dimethylaminomethyl-I,7,7 trimethylnorboman-2-exo-amine was found
to be an active catalyst for the decarboxylation of oxalacetate and that the role of two cis neighboring amino
groups was important for this activity, especially in the presence of f3-cyclodextrin. 8 These results confirms
also the cooperated role of two or three amino groups for the decarboxylation and the aldol condensation,
loke as lysine enzymes.
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Experimental
Materials Water for the kinetics studies was purified by deionization followed by distillation. Buffers for the
kinetic experiments were prepared by using commercially available extra pure reagents: bu·ffer(pH); acetic
acid-sodium acetate (4 5). Pyruvic acid (PA) obtained from Kishida Chern. (Japan) and stored under refrigeration.
Benzaldehyde and pyridinecarboxaldehydes were distilled before uses.
Cyclodextrins (CDs) used were: a.-CD from Tokyo Kasei (Japan), 99 % pure; ~-CD from Tokyo Kasei, 99
% pure; y-CD from Kishida Chern. (Japan), 97 % pure. a-, ~-, y-PACD and MA-l were prepared according to
the previous methods.3-s IH NMR spectra of materials and products were recorded with a JEOL 400 MHz
spectrophotometer.
Reactions and product analyses The stock solution of pyruvate, pyridinecarboxaldehyde and PACDs of
desired concentrations and pHs were prepared. For the reaction and the product analysis, typically, a mixture of
0.5 M of 3-PyCHO, 0.1 M of PA and 1 mM of ~-PACD in water (1 mL, pH 4.5) in a micro sample tube was
kept at 50°C for a desired time. After the reaction the solution was diluted in 100-fold and nicotinic acid as an
internal standard was added into this solution. The product analyses were performed by high 'pressure liquid
chromatography using a shimadzu LA-6A system equipped with a Shimpak Wax-l anion-exchange column
with the elution of H20-MeOH (95:5 v/v) in a flow rate of 1 mL/min.
The retention times of nicotinic acid and the product (4-(3 pyridyl)-2-keto-3,4-butenoic acid) are 11.6 and
18.9 min, respectively, detected by an UV spectrometric detector. The product yields were caluculated by
using these peak areas where the UV intensities of nicotinic acid and this product are £260 = 4,800 and £260 =
8,340, respectively. The other product yields were also calculated with a similar method. The structures of the
reaction products were confirmed by IR and NMR measurements.
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